Success Story: Without RFE Issues, Our Expert Guidance Helped A Turkish Postdoctoral Fellow Achieve NIW Immigration Approval
Client’s Testimonial:
“Thank you very much for your help and support in addition to believing in my case’s success potential more than me since day 0!”
On November 19th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Fellow in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Post-Doctoral Fellow
Country of Origin: Turkey
State of Residence at the Time of Filing: Michigan
Approval Notice Date: November 19th, 2025
Processing Time: 18 months, 28 days
Case Summary:
North America Immigration Law Group (NAILG) is pleased to announce the approval of an EB-2 National Interest Waiver (NIW) petition for a highly accomplished researcher working at the intersection of neuroscience, molecular biology, and early detection of diseases. Drawing upon our deep experience with high-impact NIW filings, we built a compelling and well-substantiated case demonstrating the client’s national importance and exceptional ability to advance urgently needed biomedical research.
With a Ph.D. in Neuroscience, the client has established recognized expertise in molecular biology, focusing on the detection of molecular-level abnormalities that can serve as biomarkers for cancer and brain-related diseases. The client currently contributes to ongoing molecular biology research within the U.S. biomedical research ecosystem, developing highly refined methods for identifying disease-associated molecular signatures. These efforts directly support national priorities in early detection, precision medicine, and chronic-disease prevention.
Excellence in Molecular Biomarker Discovery
The client’s proposed endeavor centers on discovering new biomarkers for cancer, neurodegenerative diseases, metabolic disorders, and inflammatory conditions by analyzing molecular irregularities in biological samples. This work is essential for developing innovative detection methods and therapeutic strategies, including hormone-based and immune-based treatments, that can identify disease at earlier stages and reduce long-term complications.
Influential Research Record and Growing Global Impact
The NIW petition highlighted the client’s impressive scholarly record, which includes:
-
4 peer-reviewed journal articles (including 3 as co-author)
-
10 abstracts (including 3 as first author)
-
1 preprint (as first author)
-
Gathering 138 citations to published work
These publications appear in respected, high-impact journals covering molecular biology, metabolism, endocrinology, and immunology.
Independent researchers around the world continue to rely on the client’s findings to guide work in neuroscience, feeding-behavior signaling, cancer immunology, neuroendocrine pathways, and tumor-microenvironment modulation. This broad adoption serves as compelling evidence of the client’s role in shaping ongoing investigations across multiple biomedical fields.
The petition also documented the client’s peer-review activity, including at least one completed review—a meaningful indicator that scientific publishers already recognize the client as an expert capable of evaluating complex molecular-biology research.
Expert Endorsements
To further support the NIW petition, NAILG obtained four expert recommendation letters from established researchers in neuroscience, cancer biology, and molecular genetics. These experts independently affirmed the client’s technical excellence, the global reach of the client’s publications, and the national importance of the proposed biomarker-discovery research.
“In sum, [Client’s] research in the field of molecular biology is of critical importance in reducing the mortality rates of cancer, especially aggressive metastatic forms of breast cancer with few existing treatment options. Therefore, it is my strong recommendation that she be allowed to continue her work unimpeded in the United States.”
NIW Approval and Outlook
USCIS approved the NIW petition after concluding that the client’s work offers clear and substantial benefits to the United States. The decision recognized the national importance of developing improved diagnostic and therapeutic approaches for cancer, neurodegenerative diseases, diabetes, and inflammation, all of which pose escalating burdens on U.S. public health systems.
NAILG is honored to have supported this highly promising molecular-biology researcher. We look forward to witnessing the client’s continued contributions in advancing biomarker discovery, enabling earlier disease detection, and driving next-generation medical innovation for the United States.